The beneficial effect of BM-MSCs-EV (120 μg/kg) was observed with significant decrease in serum CK-MB, LDH and cTnI levels as compared to cardiotoxicity induced by NASH group. The gene discussed is TNNI3; the disease is metabolic dysfunction-associated steatohepatitis.